Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?
Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?
复制标题
DOI:
10.1155/2017/2534653
复制
发表时间:
2017
影响因子:
4.1
通讯作者:
Byrne GW
中科院分区:
文献类型:
--
作者:
McGregor CGA;Byrne GW
Cardiac xenotransplantation (CXTx) is a promising solution to the chronic shortage of donor hearts. Recent advancements in immune suppression have greatly improved the survival of heterotopic CXTx, now extended beyond 2 years, and life-supporting kidney XTx. Advances in donor genetic modification (B4GALNT2 and CMAH mutations) with proven Gal-deficient donors expressing human complement regulatory protein(s) have also accelerated, reducing donor pig organ antigenicity. These advances can now be combined and tested in life-supporting orthotopic preclinical studies in nonhuman primates and immunologically appropriate models confirming their efficacy and safety for a clinical CXTx program. Preclinical studies should also allow for organ rejection to develop xenospecific assays and therapies to reverse rejection. The complexity of future clinical CXTx presents a substantial and unique set of regulatory challenges which must be addressed to avoid delay; however, dependent on these prospective life-supporting preclinical studies in NHPs, it appears that the scientific path forward is well defined and the era of clinical CXTx is approaching.
登录
查看更多内容
影响因子:
3.9
作者:
Abicht, Jan-Michael;Mayr, Tanja;Brenner, Paolo
通讯作者:
Brenner, Paolo
影响因子:
3.9
作者:
Bauer, A;Baschnegger, H;Christ, F
通讯作者:
Christ, F
影响因子:
37.8
作者:
Castleberry, Chesney;Ryan, Thomas D.;Chin, Clifford
通讯作者:
Chin, Clifford
影响因子:
0.9
作者:
Corcoran, P. C.;Horvath, K. A.;Mohiuddin, M. M.
通讯作者:
Mohiuddin, M. M.
影响因子:
4.7
作者:
Byrne, GW;Schwarz, A;Logan, JS
通讯作者:
Logan, JS